The Drexel Coulter Translational Research Partnership Program promotes, develops, and supports innovations to improve patient care. The program provides mentoring, project management, and funding to promising translational projects with the goal of moving innovative technologies to clinical application through commercialization. The ultimate goal of this partnership is to develop health care solutions that address unmet or underserved clinical needs and lead to improvements in patient health care.
The Drexel Coulter Translational Research Partnership Program does not fund discovery research. Unlike discovery research (the creation of new knowledge), translational research is centered on the practical clinical application of research results. Typical projects focus on applying developed technologies to solve an unmet or underserved clinical need, or to change a medical practice. Project proposals are evaluated on the basis of their clinical merit, their potential health care impact and significance, their timeline and pathway to commercialization, and most importantly their potential for obtaining further financial investment to translate the particular solution to healthcare.
Seven years into this program 26 projects received support and Drexel University has been very successful in out-licensing these technologies. Below please find a summary of our accomplishments during the first 7 years of the program. Over 40 full patent applications as well as 3 issued patents have been secured, 10 technologies have progressed to pre-clinical human study stage, 1 has gone thru FDA for veterinary usage and is in market (human FDA clearance pending) and 8 technologies have been licensed.
Grants are awarded for a one-year period, and may be submitted for renewal. The average size of the grant is $100K.